ALMODAWAT

Almodawat Specialized Medical Hospital Company

9594StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	121.82M	75.49M	74.31M	58.57M	40.84M
Cost of Revenue	69.76M	45.09M	33.93M	30.71M	26.17M
Gross Profit	52.06M	30.40M	40.37M	27.85M	14.67M
SG&A	24.23M	19.35M	15.67M	14.13M	15.56M
Operating Expenses	28.08M	22.36M	18.50M	15.71M	15.14M
Operating Income	23.99M	8.04M	21.88M	12.14M	-0.48M
Interest Expense	-2.01M	-1.13M	-1.13M	-0.69M	-0.22M
Other Income/Expense	-1.03M	-0.01M	0.04M	-0.52M	—
Pretax Income	20.28M	6.79M	19.45M	10.61M	-0.69M
Income Tax	1.31M	0.72M	0.85M	0.33M	0.03M
Net Income	18.98M	6.07M	18.59M	10.31M	-2.21M
EBITDA	27.74M	10.38M	23.62M	13.69M	0.93M
EBIT	23.99M	8.04M	21.88M	12.14M	-0.48M
EPS (Basic)	0.27	0.09	0.33	0.18	—
EPS (Diluted)	0.27	0.09	0.33	0.18	—
DPS	—	—	0.23	—	—
Margins & Efficiency
Gross Margin %	+42.7%	+40.3%	+54.3%	+47.6%	+35.9%
EBITDA Margin %	+22.8%	+13.7%	+31.8%	+23.4%	+2.3%
Net Margin %	+15.6%	+8.0%	+25.0%	+17.6%	-5.4%
Revenue & Income
Revenue	121.82M	75.49M	74.31M	58.57M	40.84M
Revenue Growth (YoY)	+61.4%	+1.6%	+26.9%	+43.4%	—
Expenses & Provisions
Advertising Expenses	1.55M	0.97M	0.16M	0.08M	—
Cost of Revenue	69.76M	45.09M	33.93M	30.71M	26.17M
Selling, General & Admin	24.23M	19.35M	15.67M	14.13M	15.56M
Operating Expenses	28.08M	22.36M	18.50M	15.71M	15.14M
Other Operating Expenses	396.64K	—	—	—	-417.05K
Interest Expense	-2.01M	-1.13M	-1.13M	-0.69M	-0.22M
Other Non Operating Income (Expenses)	-1.03M	-0.01M	0.04M	-0.52M	—
D&A For EBITDA	3.75M	2.34M	1.74M	1.55M	1.41M
Profitability & Returns
Gross Profit	52.06M	30.40M	40.37M	27.85M	14.67M
Gross Margin	+42.7%	+40.3%	+54.3%	+47.6%	+35.9%
EBIT	23.99M	8.04M	21.88M	12.14M	-0.48M
EBIT Margin	+19.7%	+10.7%	+29.4%	+20.7%	-1.2%
EBITDA	27.74M	10.38M	23.62M	13.69M	0.93M
EBITDA Margin	+22.8%	+13.7%	+31.8%	+23.4%	+2.3%
EBT Excluding Unusual Items	20.95M	6.90M	20.78M	10.92M	-0.69M
Pretax Income	20.28M	6.79M	19.45M	10.61M	-0.69M
Operating Income	23.99M	8.04M	21.88M	12.14M	-0.48M
Operating Margin	+19.7%	+10.7%	+29.4%	+20.7%	-1.2%
Profit Margin	+15.6%	+8.0%	+25.0%	+17.6%	-5.4%
Net Income	18.98M	6.07M	18.59M	10.31M	-2.21M
Net Income to Common	18.98M	6.07M	18.59M	10.31M	-2.21M
Net Income Growth	+212.4%	-67.3%	+80.3%	—	—
Earnings From Continuing Ops.	18.98M	6.07M	18.59M	10.28M	-0.73M
Income Tax Expense	1.31M	0.72M	0.85M	0.33M	0.03M
Effective Tax Rate	+6.4%	+10.6%	+4.4%	+3.1%	—
Per Share & Capital
EPS (Basic)	0.27	0.09	0.33	0.18	—
EPS (Diluted)	0.27	0.09	0.33	0.18	—
EPS Growth	+203.9%	-73.1%	+80.3%	—	—
Dividend Per Share	—	—	0.23	—	—
Shares Change (YoY)	0.03	0.22	—	—	—
Shares Outstanding (Basic)	71.25M	69.30M	57.00M	57.00M	—
Shares Outstanding (Diluted)	71.25M	69.30M	57.00M	57.00M	—
Free Cash Flow	1.90M	-8.52M	9.68M	2.32M	-2.26M
Free Cash Flow Margin	+1.6%	-11.3%	+13.0%	+4.0%	-5.5%
Free Cash Flow Per Share	0.03	-0.12	0.17	0.04	—
Payout Ratio	+15.0%	+359.8%	+50.3%	—	—
Supplemental
Other Unusual Items	-0.66M	-0.11M	-1.33M	-0.31M	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	121.82M	75.49M	74.31M	58.57M	40.84M
Cost of Revenue	69.76M	45.09M	33.93M	30.71M	26.17M
Gross Profit	52.06M	30.40M	40.37M	27.85M	14.67M
SG&A	24.23M	19.35M	15.67M	14.13M	15.56M
Operating Expenses	28.08M	22.36M	18.50M	15.71M	15.14M
Operating Income	23.99M	8.04M	21.88M	12.14M	-0.48M
Interest Expense	-2.01M	-1.13M	-1.13M	-0.69M	-0.22M
Other Income/Expense	-1.03M	-0.01M	0.04M	-0.52M	—
Pretax Income	20.28M	6.79M	19.45M	10.61M	-0.69M
Income Tax	1.31M	0.72M	0.85M	0.33M	0.03M
Net Income	18.98M	6.07M	18.59M	10.31M	-2.21M
EBITDA	27.74M	10.38M	23.62M	13.69M	0.93M
EBIT	23.99M	8.04M	21.88M	12.14M	-0.48M
EPS (Basic)	0.27	0.09	0.33	0.18	—
EPS (Diluted)	0.27	0.09	0.33	0.18	—
DPS	—	—	0.23	—	—
Margins & Efficiency
Gross Margin %	+42.7%	+40.3%	+54.3%	+47.6%	+35.9%
EBITDA Margin %	+22.8%	+13.7%	+31.8%	+23.4%	+2.3%
Net Margin %	+15.6%	+8.0%	+25.0%	+17.6%	-5.4%
Revenue & Income
Revenue	121.82M	75.49M	74.31M	58.57M	40.84M
Revenue Growth (YoY)	+61.4%	+1.6%	+26.9%	+43.4%	—
Expenses & Provisions
Advertising Expenses	1.55M	0.97M	0.16M	0.08M	—
Cost of Revenue	69.76M	45.09M	33.93M	30.71M	26.17M
Selling, General & Admin	24.23M	19.35M	15.67M	14.13M	15.56M
Operating Expenses	28.08M	22.36M	18.50M	15.71M	15.14M
Other Operating Expenses	396.64K	—	—	—	-417.05K
Interest Expense	-2.01M	-1.13M	-1.13M	-0.69M	-0.22M
Other Non Operating Income (Expenses)	-1.03M	-0.01M	0.04M	-0.52M	—
D&A For EBITDA	3.75M	2.34M	1.74M	1.55M	1.41M
Profitability & Returns
Gross Profit	52.06M	30.40M	40.37M	27.85M	14.67M
Gross Margin	+42.7%	+40.3%	+54.3%	+47.6%	+35.9%
EBIT	23.99M	8.04M	21.88M	12.14M	-0.48M
EBIT Margin	+19.7%	+10.7%	+29.4%	+20.7%	-1.2%
EBITDA	27.74M	10.38M	23.62M	13.69M	0.93M
EBITDA Margin	+22.8%	+13.7%	+31.8%	+23.4%	+2.3%
EBT Excluding Unusual Items	20.95M	6.90M	20.78M	10.92M	-0.69M
Pretax Income	20.28M	6.79M	19.45M	10.61M	-0.69M
Operating Income	23.99M	8.04M	21.88M	12.14M	-0.48M
Operating Margin	+19.7%	+10.7%	+29.4%	+20.7%	-1.2%
Profit Margin	+15.6%	+8.0%	+25.0%	+17.6%	-5.4%
Net Income	18.98M	6.07M	18.59M	10.31M	-2.21M
Net Income to Common	18.98M	6.07M	18.59M	10.31M	-2.21M
Net Income Growth	+212.4%	-67.3%	+80.3%	—	—
Earnings From Continuing Ops.	18.98M	6.07M	18.59M	10.28M	-0.73M
Income Tax Expense	1.31M	0.72M	0.85M	0.33M	0.03M
Effective Tax Rate	+6.4%	+10.6%	+4.4%	+3.1%	—
Per Share & Capital
EPS (Basic)	0.27	0.09	0.33	0.18	—
EPS (Diluted)	0.27	0.09	0.33	0.18	—
EPS Growth	+203.9%	-73.1%	+80.3%	—	—
Dividend Per Share	—	—	0.23	—	—
Shares Change (YoY)	0.03	0.22	—	—	—
Shares Outstanding (Basic)	71.25M	69.30M	57.00M	57.00M	—
Shares Outstanding (Diluted)	71.25M	69.30M	57.00M	57.00M	—
Free Cash Flow	1.90M	-8.52M	9.68M	2.32M	-2.26M
Free Cash Flow Margin	+1.6%	-11.3%	+13.0%	+4.0%	-5.5%
Free Cash Flow Per Share	0.03	-0.12	0.17	0.04	—
Payout Ratio	+15.0%	+359.8%	+50.3%	—	—
Supplemental
Other Unusual Items	-0.66M	-0.11M	-1.33M	-0.31M	—